Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    08 UX: Pushing the right buttons

    White Papers and Resources | March 31, 2014 | Havas Lynx

    Unlocking better outcomes in healthcare with UX

    UX: Pushing the right buttons

    White Papers and Resources | March 31, 2014 | Havas Lynx

    Unlocking better outcomes in healthcare with UX

    07 Good Pharma

    White Papers and Resources | January 3, 2014 | Havas Lynx

    Better for patients, better for business

    06 Our Opportunity to Rethink the Health Experience

    White Papers and Resources | January 3, 2014 | Havas Lynx

    Our point of view

    05 Social Media: A Health Hazard?

    White Papers and Resources | January 3, 2014 | Havas Lynx

    The case to embrace going social

    Creating a Lifeline to the New Digital User

    White Papers and Resources | January 3, 2014 | Havas Lynx

    Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

    Warehousing of HCV patients reaches new high

    White Papers and Resources | December 19, 2013 | Inizio

    A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

    Brand leaders in RA will lose market share, predict rheumatologists

    White Papers and Resources | December 19, 2013 | Inizio

    Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

    Removing the Roadblocks to Effective Patient Treatment

    White Papers and Resources | November 22, 2013 | Inizio

    How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

    Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

    White Papers and Resources | November 22, 2013 | Inizio

    Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...